Protagonist Therapeutics PTGX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 87.34 | 115.18 | 118.93 | -0.70 | -50,355 | -44 |
| 2025Q3 | 66.43 | 118.00 | 79.42 | -0.62 | -46,421 | -39 |
| 2025Q2 | 55.27 | 121.51 | 60.96 | -0.55 | -42,041 | -35 |
| 2025Q1 | 48.36 | 165.68 | 10.79 | -0.19 | -19,310 | -12 |
| 2024Q4 | 38.60 | 94.85 | 13.47 | 2.01 | 126,780 | 132 |
| 2024Q3 | 45.00 | 123.26 | 15.60 | -0.55 | -41,453 | -33 |
| 2024Q2 | 34.65 | 123.97 | 12.54 | -0.49 | -38,793 | -31 |
| 2024Q1 | 28.93 | 97.93 | 3.26 | 206,309 | 207 | |
| 2023Q4 | 22.93 | 84.32 | 0.52 | 23,049 | 27 | |
| 2023Q3 | 16.68 | 112.38 | -0.57 | -38,326 | -34 | |
| 2023Q2 | 27.62 | 110.12 | -0.67 | -42,354 | -38 | |
| 2023Q1 | 23.00 | 106.81 | -0.67 | -36,021 | -34 | |
| 2022Q4 | 10.91 | 106.79 | -0.70 | -36,516 | -34 | |
| 2022Q3 | 8.43 | 103.43 | -0.63 | -32,303 | -31 | |
| 2022Q2 | 7.91 | 100.99 | -0.84 | -41,443 | -41 | |
| 2022Q1 | 23.68 | 100.86 | -0.43 | -21,111 | -21 | |
| 2021Q4 | 34.20 | 100.30 | -0.77 | -37,016 | -37 | |
| 2021Q3 | 17.72 | 100.36 | -0.71 | -33,926 | -34 | |
| 2021Q2 | 44.88 | 100.13 | -0.69 | -30,882 | -31 | |
| 2021Q1 | 25.90 | 100.10 | -0.54 | -24,021 | -24 |